Anti-tumor effect of N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) on experimental pancreatic cancer

Journal of Nippon Medical School

Volumn 69, Issue 3, 2002, Pages 224-234

  Hiroi, Makoto ^a   Onda, Masahiko ^a   Uchida, Eiji ^a   Aimoto, Takayuki ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Angiogenesis; Hamster pancreatic cancer; Proliferation; Tranilast

Indexed keywords

TRANILAST;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; FEMALE; HAMSTER; METASTASIS; NONHUMAN; PANCREAS CANCER;

ANIMALS; ANTHRANILIC ACIDS; ANTINEOPLASTIC AGENTS; CELL DIVISION; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MESOCRICETUS; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0036288203     PISSN: 13454676     EISSN: None     Source Type: Journal    
DOI: 10.1272/jnms.69.224     Document Type: Article

References (43)

1. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?
2. Pancreatic cancer: Diagnosis accuracy and survival statistics
3. Recurrence of exocrine pancreatic cancer-local or hepatic?
4. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head
5. Pancreatic carcinoma
6. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer
7. Survival after pancreatoduodenectomy
8. One hundred forty-five consecutive pancreatico-duodenectomies without mortality
9. Molecular metastases in stageIpancreatic cancer: Improved survival with adjuvant chemoradiation
10. Tranilast inhibits proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo
11. Pharmacological properties of N-(3′, 4′-dimethoxycinnamoyl) anthranilic acid (N-5′), a new anti atopic agent
12. Inhibition of hypersensitivity reactions by a new drug, N-(3′,4′dimethoxycinnamoyl) anthranilic acid (N-5′)
13. Inhibition by tranilast of collagen accumulation hypersensitive granulomatous inflammation in vivo and of morphological changes and functions of fibroblasts in vitro
14. The mechanism involved in the inhibitory action of tranilast on collagen synthesis of keloid fibroblasts
15. Tranilast suppresses intimal hyperplasia in the balloon injury model and cuff treatment model in rabbits
16. Prominent inhibitory effects of tranilast on migration and proliferation of and collagen synthesis by vascular smooth muscle cells
17. Angiogenesis in cancer, vascular, rheumatoid and other disease
18. N-[3,4-dimethoxy-cinnamoyl] anthranilic acid (Tranilast) inhibits transforming growth factor β release and reduces migration and invasiveness of human malignant glioma cells
19. Rapid formation of pancreatic tumors by intrapancreatic transplantation of a newly established hamster carcinoma cell line (PGHAM-1) and its sequential analysis
20. The significance of blood group-related antigen A in a pancreatic cell line (PGHAM-1) in hamsters. With special reference to cell proliferation
21. Effect of angiostatin on liver metastasis of pancreatic cancer in hamsters
22. Effect of Cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo
23. Microvessel quantitation in invasive breast cancer by staining for factor VIII related antigen
24. Inhibition by tranilast of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF)-induced increase in vascular permeability in rats
25. Inhibitory mechanism of tranilast in human coronary artery smooth muscle cells proliferation, due to blockade of PDGF-BB-receptors
26. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma
27. The association of k-ras gene mutation and vascular endothelial growth factor gene expression in pancreatic carcinoma
28. Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer
29. Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer
30. Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF-C in gastric carcinoma
31. The biology of vascular endothelial growth factor
32. The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma moedel
33. Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors
34. Therapeutic effects of viral vector-mediated antiangiogenic gene transfer in malignant ascites
35. Expression of hyaluronan receptor, CD-44 S, in epithelial ovarian cancer is an independent predictor of survival
36. Role of α2β1 and α 3β1 integrin in the peritoneal implantation of scirrhous gastric carcinoma
37. Membrane-type matrix metalloproteinase expression and metalloproteinase-2 in primary human ovarian epithelial carcinoma cells
38. Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers: Correlation to clinical features
39. Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells
40. Adhesion molecules and TGF-β1 are involved in the peritoneal dissemination of NUGC-4 human gastric cancer cells
41. Anti-angiogenic treatment for peritoneal dissemination of pancreas adenocarcinoma: A study using TNP-470
42. Tumor vasculature as a target for anticancer therapy
43. Eosinophilic cystitis induced by tranilast: A case report